These emerging therapies , Tirzepatide , represent a significant advancement in treating metabolic dysfunction and possibly associated ailments . These drugs are classified as GLP-1 receptor agonists https://matteoojhm820758.glifeblog.com/39982531/retatrutide-a-deep-dive-into-glp-1-agents